European Journal of Obstetrics & Gynecology and Reproductive Biology
Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women
Introduction
Preeclampsia is one of the most important diseases of pregnancy and is a major cause of maternal and fetal morbidity and mortality. Although it occurs in 4–5% of all pregnancies, the pathophysiology of this syndrome is not fully understood. Clinically, preeclampsia is characterized by hypertension and proteinuria [1]. Increasing clinical and biochemical evidences suggest that a disturbance of normal endothelial cell function may be a primary cause in the pathogenesis of preeclampsia [1], [2]. In classic studies, vascular lesions in the placental bed of women with preeclampsia were reported to be similar to atherosclerotic plaques [3]. It has been suggested that an abnormal lipid profile may have a role in the pathogenesis of preeclampsia [4]. The proposed mechanisms of lipid-mediated cardiovascular pathology in adults resemble those suggested for preeclampsia and chronic abnormal endothelial hyper-stimulation through lipid peroxidation have been suggested as precursors to dysfunction and damage [5]. Oxidation of LDL-cholesterol seems to be an important step in this process. Wakatsuki et al. suggested that oxidized LDL-cholesterol particles might be involved in vascular endothelial damage in preeclampsia [6].
Paraoxonase (PON) is a lipophilic antioxidant that is bound to HDL-cholesterol. It is a protein of 354 amino acids with a molecular mass of 43 kDa, present in serum and liver, which together with arylesterase has been demonstrated to function as a single enzyme [7], [8]. A recent hypothesis suggests an antioxidant role for PON in the protection of LDL-cholesterol from oxidative modifications [9]. To the best our knowledge the PON and arylesterase levels have not been studied as yet in preeclampsia. By assuming that PON and arylesterase activities might be decreased and that these antioxidant enzymes have a role in the pathogenesis of preeclampsia, we designed the present study to determine whether the PON and arylesterase activities were decreased or not in this disease.
Section snippets
Materials and methods
This case-control study was carried out on 28 severe preeclamptic and 24 healthy pregnant women attended at the Obstetric Division of the University Hospital in Elazig, Turkey. This study was performed with the approval of the Ethics Committee and all subjects were recruited in a voluntary manner, giving their written informed consent. Normal pregnancy was diagnosed on the basis of clinical, biochemical, and ultrasound findings. Preeclampsia was diagnosed by gestational hypertension accompanied
Results
The demographic, clinical, hematological and biochemical parameters of our study subjects and controls are given in Table 1. Although the subjects’ age and parity were similar in both groups, the mean gestational times at diagnosis and delivery were shorter in the case group as compared to controls. In the case group, the levels of total cholesterol, triglycerides and LDL-cholesterol were 4-, 5- and 9.8% higher, respectively, whereas that of HDL-cholesterol was 9% lower, as compared to the
Comment
The exact cause of preeclampsia still remains elusive. Some factors that are involved to some extent include: placental ischemia, immune impairment, chronic vascular or autoimmune diseases and genetic factors. In the present study, we observed elevated serum triglycerides and LDL-cholesterol in severe preeclamptic women. This significant rise in lipid levels is in agreement with published reports [4], [5], [6], [7], [8], [9], [10], [11], [12]. Studies on animals and humans with lipidemia
References (20)
- et al.
The ultrastructure of acute atherosis in hypertensive pregnancy
Am. J. Obstet. Gynecol.
(1975) - et al.
Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia
Metabolism
(1998) - et al.
Lipoprotein particles in preeclampsia: susceptibility to oxidative modification
Obstet. Gynecol.
(2000) - et al.
Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
FEBS Lett.
(1991) - et al.
Etiology and pathogenesis of preeclampsia: current concepts
Am. J. Obstet. Gynecol.
(1998) - et al.
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis
Obstet. Gynecol.
(1997) - et al.
Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia: lipid peroxidation in preeclampsia
Pathophysiology
(2002) - et al.
Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia
Placenta
(2001) - et al.
Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women
Maturitas
(1998) - ACOG Committee on Obstetric Practice. Diagnosis and management of preeclampsia and eclampsia. American College of...